This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovations of David Willows
Introduction
David Willows is an accomplished inventor based in Oxon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new medicinal compounds. His work focuses on innovative solutions for chronic pain management.
Latest Patents
David Willows holds a patent for Triazine-oxadiazoles. This invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification. The patent also covers processes for the preparation of such derivatives, pharmaceutical compositions comprising these derivatives, and their application as a medicament for the treatment of chronic pain. He has 1 patent to his name.
Career Highlights
David is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development of innovative pharmaceutical solutions. His expertise in medicinal chemistry has been instrumental in advancing the company's product pipeline.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Jonathan Hargrave and Jonathan Mark Bentley. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
David Willows exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the development of new treatments for chronic pain highlight the importance of research and collaboration in advancing healthcare solutions.